Articles

The agreement follows Agilent’s acquisition of Canada-based CDMO BIOVECTRA in July 2024.

EquipNet, Agilent Enter Reseller Agreement for Certified Pre-Owned Instruments

Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at increased risk.


FDA Approves RSV Vaccine

The merger will create a specialty company, REGiMMUNE/Kiji TX, for regulatory T cells.

REGiMMUNE and Kiji Therapeutics to Merge

The Cambridge-GSK Translational Immunology Collaboration builds on an existing scientific relationship between the biopharma company and the university, with the aim of improving outcomes for patients.

GSK, Cambridge to Partner on R&D for Kidney and Respiratory Diseases

As many as 30% of people living with severe hemophilia A develop inhibitors such as TFPI, which can be produced by the body’s immune response to clotting factors in replacement therapy, often limiting the effectiveness of that therapy.

CHMP Gives Positive Opinion to Novo Nordisk Hemophilia Treatment

Wainzua had been previously approved for use by patients with ATTRv-PN in the United States, under the brand name Wainua.

AstraZeneca’s Polyneuropathy Treatment Recommended for EU Approval

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Cell and gene therapy experts Fabian Gerlinghaus, Dr. Claudia Zylberberg, and Benjamin McLeod weigh in on hot topics in CGT. 

Buy, Sell, Hold: Cell and Gene Therapy - Part 3

Buy, Sell, Hold: Cell and Gene Therapy - Part 2

Rather than relying on a myriad of different systems, the author proposes that a cloud-based solution can control and coordinate everything, allowing manufacturers to deftly respond when changes in labeling requirements arise.

Compliance Gap: Why Labeling and Instructions for Use Documents Need to Be a Single Process

Redica Systems has been assisting pharmaceutical companies in determining GMP quality risks at their manufacturing sites, and with AI, it has a relatively new addition to its toolbox.

News